WHAT IS THE WORLD BIOSIMILAR CONGRESS?

 

FULL VALUE
CHAIN MEETING

 

SPEED
NETWORKING

 

 

120+
ATTENDEES

 

2 FANTASTIC DAYS OF CONTENT

 

 

30+ INDUSTRY SPEAKERS

 

50+
EXHIBITORS

 

 

Evaluate case studies from the leading players in the biosimilar space.

Discover the latest strategies for the characterisation and comparability of biosimilars.

Network  with the leaders, the influencers and the key R&D professionals working in the biosimilar space.

Listen to updates from the EMA on biosimilar regulatory approval and market access success.

 

Download the prospectus 

Just a few of the pioneers we will be hearing from in 2016:

​​

  • Mr Brian Edwards at World Biosimilar Congress
    Mr Brian Edwards
    Principal Consultant
    NDA Group
  • Dr Uwe Gudat at World Biosimilar Congress
    Dr Uwe Gudat
    Head of Safety, Biosimilars
    Merck
  • Dr Ruediger Jankowsky at World Biosimilar Congress
    Dr Ruediger Jankowsky
    Managing Director
    Cinfa Biotech
  • Mr Steiner Madsen at World Biosimilar Congress
    Mr Steiner Madsen
    Medical Director
    Norwegian Medicines Agency
  • Dr Mark McCamish at World Biosimilar Congress
    Dr Mark McCamish
    Global Head Biopharm.& Oncology Injectables Development
    Sandoz
  • Professor Pierre Michetti at World Biosimilar Congress
    Professor Pierre Michetti
    Gastroenterologist
    Centre Hospitalier Universitaire Vaudois
  • Mr Cecil Nick at World Biosimilar Congress
    Mr Cecil Nick
    Vice President
    PAREXEL
  • Michael Reilly at World Biosimilar Congress
    Michael Reilly
    Executive Director
    Alliance for Safe Biologic Medicines
  • Dr Steffen Thirstrup at World Biosimilar Congress
    Dr Steffen Thirstrup
    Director, NDA Regulatory Advisory Board
    NDA Advisory Services Ltd
  • Mr Tony Williams at World Biosimilar Congress
    Mr Tony Williams
    General Manager
    TWC Pharma Consulting GmbH

 

SEE MORE SPEAKERS

2015 ATTENDEES INCLUDED:

 

Merck - biosimilar attendee

Pall Life Sciences - biosimilar attendee

abbvie - biosimilar attendee

Bucher biotec - biosimilar attendee

Safe Biologics - biosimilar attendee

aldevron - biosimilar attendee

Genovis - biosimilar attendee

Express Scripts - biosimilar attendee

 

ATTEND 2016 EVENT

"It is an excellent meeting for getting updates and it is very relevant to the current status of biosimilar development."


Senior Consultant, N.D.A. Regulatory Science Ltd

BRINGING TOGETHER ALL BIOSIMILAR STAKEHOLDERS

 

Why get involved?

Why sponsor?

Why exhibit?

The 5th annual World Biosimilar Congress is the region’s most targeted market place for biosimilar and biobetter stakeholders: an exhibition, a strategic keynote conference and real life case studies.

 

  • Speak to a room full of biosimilar experts

  • Host a roundtable and meet your customers

  • Take advantage of 1-2-1 partnering

  • Let us generate sales leads pre-event

  • Hundreds of private meetings arranged

 

  • Show off your latest products & innovations

  • Promote new services

  • Brand new Platform Technology stream

  • Generate new sales leads

  • Raise brand profile

Download the sponsorship prospectus

CO-LOCATED WITH:

World Immunotherapy Congress

World HPAPI Congress 2016

 

"First-class programme, containing the thought-leaders in the field.Advisory Board Member and Immunogenicity Expert."

 

Advisory Board Member and Immunogenicity Expert, NDA Group

 

INTERACTIVE SESSIONS OFFER HIGH LEVEL NETWORKING 

 

 

World Biosimilar Congress 2016 round table

"It was a very informative event with lots of good topics and speakers."
Kai Li Loh, Duopharma

World Biosimilar Congress 2016

"It is an excellent meeting for getting updates and it is very relevant to the current status of biosimilar development."
Niamh Kinsella, NDA Group

World Biosimilar Congress 2016 audience

"Highly focussed meeting with most participants being open to sharing experiences and data."

Steve Megit, Immunocore Ltd